New research into biological interplay between Covid-19 and cancer

The Covid-19 pandemic has impacted virtually every aspect of cancer care and research – from introducing new risks for cancer patients to disrupting the delivery of cancer treatment and the continuity of cancer research, a review of scientific literature shows. The report, by researchers at Dana-Farber Cancer Institute and other institutions, suggests that while Covid-19 has complicated the treatment of cancer patients, it has also spurred creative solutions to challenges in clinical care, and research into the new disease is benefiting from insights gained over years of cancer research. While much remains to be learned about the intersection of cancer